Bio Protocol vs Kaia — how do they compare? Bio Protocol trades at Rp499.97 (market cap Rp1,12T, Rp283,83M 24h volume), while Kaia trades at Rp609.7 (market cap Rp3,87T, Rp76,7M 24h volume). The key difference: Kaia is far larger — about 3.5× Bio Protocol's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while Kaia's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Kaia for 29 Days on average.
| BIO | KAIA | |
|---|---|---|
Market Cap | Rp1,12T | Rp3,87T |
Volume (24h) | Rp283,83M | Rp76,7M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 6,4B KAIA |
Typical Hold Time | 16 Days | 29 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Kaia is currently trading at Rp618.63 with a market cap of Rp3.92T, showing bearish technical signals with selling pressure outweighing buying signals 11-6. The token is trading near key support at Rp616 with resistance at Rp630. Technical indicators show mixed signals with neutral RSI readings but bearish moving average alignment. No major protocol updates or ecosystem developments were identified in recent analysis.
Overall outlook remains cautious with the bearish technical structure suggesting potential downside toward Rp589 support. Key opportunities include potential bounce from support levels, while major risks include continued selling pressure and lack of recent fundamental catalysts. Investors should monitor volume patterns and key support breaks for directional cues.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Kaia is a high-performance public blockchain that brings Web3 to the fingertips of millions across Asia. It was formed through the merger of the Klaytn and Finschia blockchains, initially developed by Kakao and LINE, respectively. Kaia represents Asia's largest Web3 ecosystem, seamlessly integrated with the KakaoTalk and LINE messaging platforms, which boast a combined user base of over 250 million. This allows users to experience Web3 with the ease and speed of Web2, all within their favorite super apps, enabling them to connect, create, collaborate, and contribute to the ecosystem.
Read more on KAIA →